A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease
- PMID: 9349554
- DOI: 10.1046/j.1471-4159.1997.69052087.x
A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease
Abstract
Hyperphosphorylated tau (PHF-tau) is the major constituent of paired helical filaments (PHFs) from Alzheimer's disease (AD) brains. This conclusion has been based largely on the creation and characterization of monoclonal antibodies raised against PHFs, which can be classified in three categories: (a) those recognizing unmodified primary sequences of tau, (b) those recognizing phosphorylation-dependent epitopes on tau, and (c) those recognizing conformation-dependent epitopes on tau. Recent studies have suggested that the antibodies recognizing primary sequence and phosphorylation-dependent epitopes on tau are unable to distinguish between normal adult biopsy tau and PHF-tau. We now present evidence for a new fourth class of monoclonal antibodies recognizing conformation-dependent phosphoepitopes on tau, typified by TG-3, a monoclonal antibody raised to PHFs from AD brain homogenates. Studies using a series of deletional tau mutants, site-directed tau mutants, and synthetic peptides enable the precise epitope mapping of TG-3. Additional studies demonstrate that TG-3 reacts with neonatal mouse tau and PHF-tau but does not recognize adult mouse tau or tau derived from normal human autopsy or biopsy tissue. Further investigation reveals that TG-3 recognizes a unique conformation of tau found almost exclusively in PHFs from AD brains.
Similar articles
-
Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.J Neurochem. 1996 Dec;67(6):2405-16. doi: 10.1046/j.1471-4159.1996.67062405.x. J Neurochem. 1996. PMID: 8931473
-
Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.Biochemistry. 1997 Jul 1;36(26):8114-24. doi: 10.1021/bi970380+. Biochemistry. 1997. PMID: 9201960
-
Analysis of paired helical filaments (PHFs) found in Alzheimer's disease using freeze-drying/rotary shadowing.J Struct Biol. 1993 Sep-Oct;111(2):85-95. doi: 10.1006/jsbi.1993.1039. J Struct Biol. 1993. PMID: 8130039
-
Tau protein and the neurofibrillary pathology of Alzheimer's disease.Ann N Y Acad Sci. 1996 Jan 17;777:121-31. doi: 10.1111/j.1749-6632.1996.tb34410.x. Ann N Y Acad Sci. 1996. PMID: 8624074 Review.
-
Characterization of paired helical filaments by scanning transmission electron microscopy.Microsc Res Tech. 2005 Jul;67(3-4):126-40. doi: 10.1002/jemt.20188. Microsc Res Tech. 2005. PMID: 16104001 Review.
Cited by
-
Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1085-97. doi: 10.1007/s10571-006-9083-3. Epub 2006 Jun 16. Cell Mol Neurobiol. 2006. PMID: 16779670 Review.
-
Tau in Alzheimer disease and related tauopathies.Curr Alzheimer Res. 2010 Dec;7(8):656-64. doi: 10.2174/156720510793611592. Curr Alzheimer Res. 2010. PMID: 20678074 Free PMC article. Review.
-
Propofol directly increases tau phosphorylation.PLoS One. 2011 Jan 31;6(1):e16648. doi: 10.1371/journal.pone.0016648. PLoS One. 2011. PMID: 21304998 Free PMC article.
-
Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau.J Biol Chem. 2018 Aug 3;293(31):12081-12094. doi: 10.1074/jbc.RA118.003557. Epub 2018 Jun 13. J Biol Chem. 2018. PMID: 29899114 Free PMC article.
-
Conformation determines the seeding potencies of native and recombinant Tau aggregates.J Biol Chem. 2015 Jan 9;290(2):1049-65. doi: 10.1074/jbc.M114.589309. Epub 2014 Nov 18. J Biol Chem. 2015. PMID: 25406315 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous